Management of Necrobiosis Lipoidica Diabeticorum
Optimal Metabolic Control
- Achieving strict glycemic control with HbA1c <7% may slow disease progression, as nonenzymatic glycosylation of collagen may contribute to NLD pathogenesis, according to the American Diabetes Association 1
- Optimizing blood pressure control to <140/80 mmHg with ACE inhibitors or ARBs as first-line agents is recommended, as stated by the American Diabetes Association 1
- Treating hyperlipidemia aggressively with statin therapy regardless of baseline LDL levels is advised, as suggested by the American Diabetes Association 1
- Implementing mandatory smoking cessation is crucial, as tobacco use worsens microvascular complications, according to the American Diabetes Association 2
Monitoring and Prevention of Complications
- Performing annual comprehensive foot examinations to identify loss of protective sensation and peripheral arterial disease is recommended, as stated by the American Diabetes Association 2
- Assessing vascular status with ankle-brachial index if healing is delayed is advised, according to the American Diabetes Association 2